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In this paper, we describe the synthesis of a novel copper ion hapten using the copper mercaptide of penicillenic acid (CMPA) 
derived from penicillin. Results from tests with immune rabbits indicate that: (i) A new antigen synthesized with CMPA has 
good stability and is safe for immunizing animals with no toxic phenomena being found in animal experiments; (ii) the immu-
nogenic antigen (CMPA-BSA) can stimulate the immune system to produce specific antibodies with high titrations, up to 
150000; and (iii) antibodies in antisera showed higher affinity to OVA-GSH-CuCl than OVA-GSH, which indicates that the 
antibodies have specific affinity towards copper ions. These results confirm that the novel hapten and relevant antigen for 
copper ion have been successfully synthesized, giving progress towards an immunoassay for copper ions in environmental and 
food samples.  
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Heavy metals are a class of persistent toxic contaminants 
and residues found at various levels in the environment and 
in agricultural and industrial products [1]. Unlike car-
bon-based contaminants that can be completely degraded to 
relatively harmless products, metal ions can be transformed 
in only a limited number of ways through chemical or bio-
logical remediation processes [2]. What is worse, through 
biomagnifications, heavy metal ions existing in the envi-
ronment can invade the human body and remain there for a 
long time, posing a serious threat to human health [3]. 
Copper is an essential element of some metalloenzymes 
necessary for the normal course of biochemical processes 
but, like other heavy metals, it is toxic at high concentration 
[4,5]. All of these factors pose potential risks for the envi-
ronment and human health [6] and therefore copper and 
other heavy metals must be monitored and identified in the 
environment.  
The traditional technologies for detecting heavy metals 
are instrument-based measurements such as atomic absorp-
tion spectrometry [7], inductively coupled plasma spectros-
copy (ICP-AES and ICP-MS) [8] and stripping voltammetry 
[9]. Although these conventional instruments accurately 
detect the amount of metal in an individual sample, they all 
require expensive laboratory equipment in a centralized 
facility and sample turnaround is slow. In addition, instru-
mental analyses provide no information about the metal 
oxidation state.  
In this case, immunoassays based on the affinity and 
specificity of an antigen-antibody reaction offer an alterna-
tive approach in the field of metal ion measurement. Com-
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pared with the traditional detection methods described 
above, these assays have significant advantages. Immuno-
assays are time-saving, low-cost, simple to perform, porta-
ble, and are feasible for on-site detection. They can also be 
both highly sensitive and selective. Immunoassays date back 
to the late 1950s when Yalow and Berson published their 
work on the development of a quantitative immunological 
method that could detect human insulin at picogram (pg) lev-
els in small samples of body fluid [6,10,11]. Since then, im-
munoassays have been widely applied in biology, medicine, 
agriculture and environment sciences. In the field of heavy 
metal ion analyses, immunoassays have had a long develop-
ment process [12–17]. In the 1980s, Meares et al. [18–22] 
first developed a series of methods for synthesizing com-
plexes of metal-chelate-antibodies for clinical medical ra-
dio-imaging analysis. Blake et al. [12,13,16] performed 
systemic research into synthesizing monoclonal antibodies 
to heavy metals by immunizing BALB/c mice with relevant 
antigens, antibody-based sensors for metal ions detection 
and relevant heavy metal immunoassays during the follow-
ing years. To date, immunoassays based on specific anti-
bodies for lead, indium, mercury, uranium and cadmium 
have been reported [23–29].  
The development processes for immunoassays of metal 
ions include the following procedures: designing and pre-
paring a hapten of metal ions, synthesizing antigen, im-
munizing animals, screening the antiserum, optimizing the 
immunoassay, obtaining polyclonal antibodies from the 
antiserum, selecting a monoclonal antibody with specific 
affinity to the metal ion and the ultimate application of the 
monoclonal antibody in the immunoassay for metal ion. 
Amongst these procedures, the design of the hapten is the 
key step in the development of an immunoassay method for 
detection of metal ions in environmental and food samples. 
It has been shown that a suitable hapten design determines 
the features of the synthesized antibodies, which in turn 
determines the specificity and selectivity of the immunoas-
say [30]. The traditional design concept for metal ion hap-
tens is through utilizing metal ions covalently conjugated to 
chelators (such as EDTA and DTPA) but in this approach, 
the monoclonal antibodies induced by the metal-chelate-       
protein complex preferably bind to the cage-like met-
al-chelate structure, rather than certain metal ions [28,31]. 
Wylie et al. [17] proposed a new hapten design method by 
covalently coupling mercuric ion to the –SH group in glu-
tathione. The hapten was subsequently linked to a carrier 
protein keyhole limpet hemocyanin (KLH) via amide bond. 
This experiment showed that antibodies induced by the an-
tigen (KLH-GSH-HgCl) could specifically bind to mercuric 
ions [17]. Penicillin, an unstable compound, could be de-
rived as a stable mercuric or copper mercaptide of peni-
cillenic acid (MMPA or CMPA) and used for self-determina- 
tion via catalysis of imidazole [32,33]. The derivative of 
MMPA or CMPA has a unique oxazolone ring instead of 
the β-lactamic ring in penicillin (Figure 1).  
The structure of the oxazolone ring in MMPA/CMPA 
results in characteristic ultraviolet absorption at about 325 
nm [32,33], which could be useful for identification. 
In this work, we synthesized a derivative of CMPA based 
on penicillin degradation [32,33] and successfully used the 
derivative as a novel copper ion hapten. As will be shown 
below, the hapten could be used as an effective bi- 
 
 
Figure 1  Synthesis procedures for CMPA and CMPA-BSA from penicillin G. 
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functional coupling agent to bridge the copper ion and the 
carrier protein (BSA or OVA), and could stimulate animals 
to yield high titer antibodies in serum. Below, we describe 
the relevant synthesis, characteristics, animal immunization 
and titers of antibodies in serum.  
1  Materials and methods  
1.1  Chemicals and reagents  
Bovine serum albumin (BSA) was purchased from Lizhu 
Dongfeng Biotech Co. (Shanghai, China). Reduced L-Gluta- 
thione (GSH), imidazole, CuCl2, ascorbic acid and 30% hy-
drogen peroxide were obtained from Shanghai Chemical 
Reagents Co. (Shanghai, China). 1-ethyl-3-(3-dimethyl-      
amino-propyl) carbodiimide hydrochloride (EDC.HCL.) was 
purchased from BBI Company. Penicillin G (1650 units mg1), 
Ampicillin, ovalbumin egg (OVA), complete and incomplete 
Freund’s adjuvants were purchased from Sigma-Aldrich 
Chemical Co. (St Louis, MO, USA). Tween-20, TMB, goat 
anti-rabbit IgG conjugated with HRP were purchased from 
Shanghai Shenhang Chemical Reagents Co. (Shanghai, Chi-
na). New Zealand Rabbits were purchased from Shanghai 
SLK Experimental Animal Co. (Shanghai, China). All rea-
gents available were at their highest purity grade.  
1.2  Apparatus 
Infrared (IR) spectra were taken in a Bruker EQUINOX 55 
Fourier Transform Infrared Raman Spectroscope (Bruker, 
Karlsruhe, Germany). ICP-AES measurements were per-
formed on a Thermo Fisher Iris Advantage 1000 inductive 
coupling plasma emission spectrograph (Thermo Fisher, 
Waltham, USA). UV and visible spectra were recorded with 
a Thermo Electron Evolution 300 UV-Vis spectrophotome-
ter. A Shanghai KHB ST-360 Microplate Reader was ap-
plied in the ELISA test (Shanghai KHB, Shanghai, China). 
The pH measurements were made by using a Delta 320 in-
strument (Mettler Toledo, Zurich, Switzerland). 
1.3  Buffer and solution  
PBS, 50 mmol L1, pH 7.4; carbonate buffer, 50 mmol L1, 
pH 9.6; PBS washing buffer (PBST): PBS, 50 mmol L1 
with 0.05% Tween 20; DMSO, 10% v/v; 4% NaHCO3; sub-
strate solution for horseradish peroxidase: (i) tetra-
methybenzidin, 10 mg mL1, TMB was diluted in 0.6% 
DMSO; (ii) pH 5.5 citrate-acetate buffer solution (CPBS: 
100 mmol L1 citric acid, 200 mmol L1 Na2HPO4); (iii) 
H2O2, 30%; (iv) 2 mol L
1 H2SO4 .  
1.4  Synthesis of CMPA hapten and antigens 
The synthesis procedure for CMPA was described in pre-       
vious work [32,33]. Brief steps are given below. Step 1: 
dissolve 40 mg penicillin G and 0.7 g imidazole in 10 mL 
aqueous solution, which was adjusted with 1 mol L1 HCl to 
pH 6.80 and gently stirred for 10 min at room temperature. 
Step 2: add 10 mg mL1 CuCl2 dropwise to the aqueous so-
lution. Step 3: incubate the solution for 1 h at 65°C. Step 4: 
acidify the solution with 1 mol L1 HCl to obtain a grey 
precipitate of CMPA as in Figure 2. Step 5: wash the pre-
cipitate three times by 1 mol L1 HCl and two times by dis-
tilled water to remove unreacte penicillin G and CuCl2. 
CMPA was coupled to BSA or OVA via the catalyst 
EDC/HCl. The amino group in the structure of CMPA was 
linked to the carrier proteins. To achieve the ideal coupling 
ratio between CMPA and BSA, a number of factors (e.g., 
reaction time and reaction molar ratio of BSA and CMPA) 
were investigated. UV-Vis spectrometry was applied to 
monitor whether the CMPA was linked to the BSA. 
ICP-AES was used to determine the coupling ratio of 
CMPA and BSA. The procedures for synthesis and identi-
fication for coating the antigen CMPA-OVA were similar to 
those of CMPA-BSA.  
Using previously described procedures [17], two coating 
antigens (OVA-GSH and OVA-GSH-CuCl) were synthe-
sized to determine the specific affinity of antiserum to cop-
per ions. ICP-AES was applied to identify the coupling ratio 
of OVA-GSH-CuCl. 
1.5  Rabbit and mouse immunization 
Four male New Zealand white rabbits were immunized with 
antigens at a 25:1 coupling ratio of CMPA to BSA. 1 mg 
CMPA-BSA was emulsified with Freund’s complete adju-
vant (1:1 volume ratio) and injected intradermally at multi-
ple hypodermic sites on the back of each rabbit for the basic 
immunization. After two weeks, a second immunization 
was administered with the same emulsified CMPA-BSA. 
Third and fourth treatments were conducted at biweekly 
intervals. Each rabbit was bled 7 d after the third immuniza-
tion, for screening their antisera.  
The BALB/c mouse was used for the immunization with 
the antigen CMPA-BSA above, in accordance with the pro-
cedure described in detail by Wylie et al. [16,17]. 
Antisera from these two experiments were isolated via  
 
 
Figure 2  Mixed solution of the synthesized reaction of CMPA. A, Before 
water bath at 65°C. B, After the water bath at 65°C. C, After the acidifica- 
tion by 1 mol L1 HCl. The precipitate of the solution is CMPA. 
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centrifugation with thiomersal added as a preservative and 
stored at 20°C before further study [34]. 
1.6  Titration test of antisera 
Titers of the antiserum from each immune rabbit and mice 
were screened by indirect noncompetitive ELISA, with 
negative antiserum as a control according to the following 
procedure. First, 96-well microtiter plates were coated with 
100 L/well of 5 g mL1 coating antigen CMPA-OVA in 
carbonate buffer solution for 3 h in a 37°C water bath. Se-
cond, after three washes with PBST, the plates were 
blocked with 200 L/well 1% OVA (w/v). After 1 h incu-
bation in a 37°C water bath, the plates were washed as de-
scribed previously. Third, serial dilutions (1/4000, 1/50000, 
1/100000, 1/150000, etc.) of antiserum were conducted in 
10 mmol L1 pH 7.4 PBS containing 1% OVA (w/v). 100 
L/well of diluted antiserum was transferred to the plates 
and, after incubating in a 37°C water bath for 2 h, the plates 
were washed with PBST. Fourth, 100 L/well goat anti-      
rabbit IgG conjugated with horseradish peroxidase (1:5000 
dilution) in 10 mmol L1 pH 7.4 PBS containing 1% OVA 
(blocking solution) was added and then incubated in the 
37°C water bath for 1 h. Fifth, after PBST washing, 100 L 
of substrate buffer was added to each well. Sixth, after in-
cubation for 15 min, the reaction was stopped by 2 mol L1 
H2SO4 and the A value of each well was read at 450 nm 
using a Shanghai KHB ST-360 Microplate Reader. The titer 
dilution of the antibody was considered positive in case 
where the A value was more than 2.1 times that of the nega-
tive antiserum. 
1.7  Analyses of antibodies in antiserum specificity to 
CMPA and copper 
The antibody affinity to CMPA was screened by indirect 
noncompetitive ELISA. Microtiter plates with 96 wells 
were coated with 100 L/well 5 g mL1 coating antigen 
CMPA-OVA in CBS. After 3 h incubation in a water bath, 
the plates were blocked by 1% OVA. Meanwhile, the blank 
wells were coated with 1% OVA in CBS. Then 100 L/well 
antiserum (1/1000 dilution) containing 1% OVA was added. 
The rest of the steps were similar to those described for the 
titration test. The absorbance value was read at 450 nm by a 
Shanghai KHB ST-360 Microplate Reader.  
The antibodies’ specific affinity to copper ions was fur-
ther investigated via the coating antigens of OVA-GSH and 
OVA-GSH-CuCl. Both of these antibodies were diluted to 
20 g mL1 by 50 mmol L1 pH 9.6 carbonate buffer solu-
tion (CBS). 100 L/well OVA-GSH or OVA-GSH-CuCl 
was added. After 1 h incubation in the 37°C water bath, the 
plates were blocked by 1% OVA. Then 100 L/well 1/500 
dilution antisera containing 1% OVA was added and incu-
bated for 1 h. The remaining steps were similar to those 
described above.  
2  Results and discussion 
2.1  Characteristics of hapten CMPA 
CMPA has a unique oxazolone ring instead of the -lac-     
tamic ring present in penicillin G, resulting in a characteris-
tic UV absorption peak at about 325 nm. The comparison of 
UV-Vis spectra between CMPA and penicillin G is shown 
in Figure 3, revealing a characteristic 325 nm absorption 
peak of CMPA in the precipitate, which confirms the suc-
cessful synthesis of CMPA. In addition, the analysis of 
UV-Vis spectra of CMPA conjugated with carrier protein 
(BSA or OVA) further indicates the existence of the oxazo-
lone ring in CMPA.  
IR analysis was also used to confirm the synthesis of 
CMPA. Figure 4 shows the IR spectra of CMPA and peni-
cillin G. In the spectrum of CMPA, the 1774 cm1 feature 
band of the -lactamic ring disappeared, demonstrating that 
the -lactamic ring was completely degraded in the process 
of CMPA synthesis. The existence of –C–C–CO (,  un-
saturated ketone) and –SH (–S–Cu) were shown by charac-
teristic bands at 1665 and 2540 cm1, respectively. Addi-
tionally, other nonspecific bands existed in both CMPA and 
penicillin G sodium, such as at 700, 750 (monosubstitution 
on aromatic ring), 2927 (–CH2), 1396 and 1400 cm
1 
[–C(CH3)2]. Clearly, these results further confirmed the 
successful synthesis of the hapten CMPA.  
Obviously, from the experimental results shown in Fig-
ures 3–5, we have successfully synthesized CMPA from 
penicillin G.  
2.2  Characterization of CMPA-BSA and CMPA-OVA 
For the preparation of animal immune experiments and in-
direct noncompetitive ELISA, the immune antigen CMPA-     
BSA and the coating antigen CMPA-OVA were synthesized  
 
 
Figure 3  UV-Vis spectra of penicillin G and hapten CMPA. 
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Figure 4  Infrared spectra of penicillin G (A) and CMPA (B). 
 
Figure 5  UV-Vis spectra of CMPA-BSA (A) and CMPA-OVA (B). 0.10 
mg mL1 CMPA-BSA and CMPA-OVA solution, or BSA and OVA solu-
tion were prepared, then scanned over 190–450 nm wavelengths by a  
Thermo Electron Evolution 300 UV-Vis spectrophotometer. 
and UV-Vis spectrometry was used to identify the conjuga-
tion between the hapten CMPA and BSA or OVA. As 
shown in Figure 5, there is a maximum absorption peak at 
about 325 nm in the ultraviolet spectra of CMPA-BSA and 
CMPA-OVA, which implies the successful conjugation 
between the CMPA and BSA (OVA). 
Additionally, because Figure 1 shows the existence of 
–S–CuCl in CMPA, ICP-AES could be applied to monitor 
the synthesis of CMPA and the successful linkage between 
CMPA and BSA or OVA. From the information shown in 
Tables 1 and 2, we concluded that even after the antigen 
(CMPA-BSA and CMPA-OVA) purification process by 
dialysis treatment in PBS, the copper ions are still present in 
the antigens, indicating the stability of the CMPA. On the 
other hand, an obvious phenomenon was found during the 
preparation of the antigen CMPA-BSA: If the reaction mo-
lar ratio (CMPA and BSA, M) was set at 10:1, the coupling 
ratio was constant at 6:1 after 6 h reaction and further reac-
tion time had no significant influence on the ratio. However, 
if M was set at 100:1, the coupling ratios would undergo a 
change from 7:1 to 24:1 when the reactive time was in-
creased from 2 to 14 h, respectively. These results clearly 
demonstrated that the reaction conditions have a strong in-
fluence on the coupling ratio of CMPA and BSA. A similar 
result was found for the synthesis of the coating antigen 
CMPA-OVA shown in Table 2. 
2.3  Titers of antisera 
As shown in Figure 6, the titer dilution of antibodies in the  
Table 1  Influence of synthesis conditions on binding ratio of 
CMPA:BSAa) 
Reaction time (h) 
Coupling ratio 
(M=10:1)b) (M=100:1)b) 
2 4:1 7:1 
6 6:1 11:1 
12 6:1 20:1 
14 6:1 24:1 
a) After reaction, unreacted CMPA was removed by dialysis. Then, an-
tigen solution was diluted to a certain concentration. Copper ion concentra-
tion of CMPA-BSA was detected by ICP-AES. b) M represents the molar 
ratio between CMPA and BSA before reaction. 
Table 2  Influence of synthesis conditions on binding ratio of 
CMPA:OVAa) 
Reaction time (h) 
Coupling ratio 
(M=10:1)b) (M=100:1)b) 
2 4:1 3:1 
6 4:1 5:1 
12 4:1 5:1 
14 4:1 5:1 
a) After reaction, unreacted CMPA was removed by dialysis. Then, an-
tigen solution was diluted to a certain concentration. Copper ion concentra-
tion of CMPA-OVA was detected by ICP-AES. b) M represented the molar 
ratio between CMPA and OVA before reaction. 
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Figure 6  Serum’s titration test of two rabbits after final boosting immunization (binding ratio of CMPA-BSA was 24:1). We used indirect ELISA here. 
Before test, immunizing serum and normal serum for each rabbit were diluted 4000, 20000, 70000, 80000, 100000, and 150000 times. 
 
antisera was considered positive when the A value at 450 
nm was more than 2.1 times that of the negative control 
antiserum. It was clearly revealed that (i) the titer of anti-
bodies in the antisera was high, even if the antiserum dilu-
tion was as high as 150000; (ii) among four immune ani-
mals, rabbit 2 showed the highest titers of antiserum, which 
implies that rabbit 2 antiserum is the optimal candidate for 
subsequent experiments.  
2.4  Affinity of the antiserum to CMPA 
In this section, the affinity of the antibodies in rabbit anti-
serum to CMPA was detected via indirect noncompetitive 
ELISA. Figure 7 shows results that demonstrate the antise-
rum’s affinity to CMPA. Compared with the titers of the 
negative control serum and the good coating with 1% OVA, 
the antibodies had a higher affinity to the coating antigen 
CMPA-OVA.  
Furthermore, the ELISA determination of the mouse an-
tiserum was processed to investigate the affinity of antibod-
ies in antiserum to CMPA. The results listed in Table 3 in-
dicate that (i) antibodies of five mice antisera all displayed a 
low level of affinity to the coating antigen OVA; (ii) it was 
observed that the antisera of mouse 4 and 5 showed favorable 
titers with higher affinity towards the antigen CMPA-OVA. 
These results demonstrate that our novel synthesized 
hapten CMPA had immunogenicity that stimulated the ani-
mals’ immune systems to produce the high affinity anti-
body.  
 
Figure 7  Affinity of antibody in antiserum to CMPA. N, Normal serum 
for negative control; O, immunized serum, coating with antigen was 1% 
OVA; O-h, immunized serum, coating antigen was OVA-CMPA. Before 
the ELISA analyses, antisera were diluted 1000-fold. The blank wells (O) 
were coated with OVA. Wells (O-h) coated with antigen CMPA-OVA  
were utilized to detect specific affinity to CMPA. 
2.5  Specific affinity of serum antibody towards copper 
After completing the experiments above, we further inves-
tigated the specific affinity of antibodies in antiserum 
against copper ions. We synthesized two coating antigens, 
OVA-GSH and OVA-GSH-CuCl, through related research 
work [17,35]. In the structure of OVA-GSH-CuCl, the cou-
pling ratio was 1:5, as detected by ICP-AES. As shown in  
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Table 3  The antibody titer in mouse antiserum by ELISA after the third 
boosting immunization with CMPA-BSA 
Mouse Neutralized with 
Antibody titer 
CMPA-BSAa) BSAa) 
No. 1 BSA <1000 <1000 
No. 2 BSA <1000 <1000 
No. 3 BSA <1000 <1000 
No. 4 BSA 1000 <1000 
No. 5 BSA 2000 <1000 
Normal BSA <1000 <1000 
a) The antigen (10 g mL1) was coated on the ELISA plate. 
 
 
Figure 8, the affinity of antibodies in serum of rabbit 2 to 
OVA-GSH-CuCl showed a favorable titer with an A450 val-
ue of 0.771, which is higher than that of the negative control 
serum (A450, 0.332) and wells coated with antigen OVA- 
GSH (A450, 0.692). The different affinities of the antiserum 
towards OVA-GSH-CuCl and OVA-GSH indicates that the 
antibodies specific to the copper ion existed in the antise-
rum of the rabbit. The detailed results of the four rabbits are 
shown in Table 5, indicating that the antibodies (rabbit) 
induced by the antigen CMPA-BSA had a specific affinity 
against copper ions. 
The detailed results regarding whether antibodies of the 
immunized mouse antiserum have specific affinity against 
copper ions are shown in Table 4. The antiserum was neu- 
 
Figure 8  Affinity of antibody in the antiserum of rabbit 2 for copper ions. 
N, Normal serum for negative control; O, immunized serum, with coating 
antigen OVA-GSH; O-m, immunized serum, with coating antigen  
OVA-GSH-Cu. 
tralized with BSA before applying the ELISA. Subsequently, 
the titers of the antibody to the CMPA-BSA, BSA, Cu- 
GSH-OVA and GSH-OVA were determined. It can be ob-
served in Table 4 that the five immunized mice 4 and 5 
produced high affinity antibodies to the CMPA hapten. 
However, there was no obvious difference observed be-
tween the antibodies’ affinities against OVA-GSH-CuCl 
and OVA-GSH in the antisera of mice.  
Table 4  ELISA test on antibody titer in mouse antiserum after 3rd boosting immunization with CMPA-BSA 




CMPA-BSAb) BSAb) Cu-GSH-OVAb) GSH-OVAb) 
No. 1 BSA <1000 <1000  <1000 <1000 
No. 2 BSA <1000 <1000  <1000 <1000 
No. 3 BSA <1000 <1000  <1000 <1000 
No. 4 BSA 1000 <1000  1000 1000 
No. 5 BSA 2000 <1000  1000 1000 
Normal BSA <1000 <1000  <1000 <1000 
a) The first dilution of serum sample with PBS was 1000. b) The antigen (CMPA-BSA) was coated on the ELISA plate. 
 
 
Table 5  Comparisons of the A values between OVA-GSH and OVA- 
GSH-CuCl coating antigens 
Rabbit OVA-GSH OVA-GSH-CuCl Relative differencea) 
No. 1 0.657±0.035 0.689±0.042 4.8 
No. 2 0.692±0.032 0.771±0.034 11.4 
No. 3 0.626±0.028 0.639±0.026 2.07 
No. 4 0.682±0.039 0.724±0.046 6.15 
a) The relative difference was calculated by the formula: [(A450 of 
OVA-GSH-CuClA450 of OVA-GSH)/(A450 of OVA-GSH)]×100%. Each 
number represents the average of triplicate determinations. 
 
Both the results of rabbit and mouse immune experi-
ments indicate that there is a weak specific affinity existing 
between the antibodies in antiserum and copper ions. The 
weak affinity of antibody to copper ions might be caused by 
the following. First, in the structure of CMPA, there are 
three epitopes: the oxazolone ring, the phenyl ring and the 
–S–CuCl group. Compared with the former two groups with 
strong immunogenicity, the –S–CuCl group has only a weak 
impact on the animal immune system. Because of the large 
size of the oxazolone ring and the phenyl ring, the –S–CuCl 
epitopes shielded by these two groups and there are few 
opportunities for recognition by the animal immune system. 
Thirdly, the connecting arm bridging between the copper 
ion and carrier protein BSA in the molecular structure of 
CMPA is –S–C–C–CO– (shown in Figure 1), which is not 
long enough to give the copper ion of CMPA full exposure 
to the immune system of animals and this strengthens the 
space shielding efficiency of the other groups around the 
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–S–CuCl epitope [17,30].  
Two approaches were taken to solve this problem. Ini-
tially, through the production of monoclonal antibody, we 
obtained an antibody with highly specific affinity to copper 
ions, but it is a time-consuming process and usually requires 
expensive equipment and reagents [34]. Second, we could 
add a sample pretreatment step before starting the copper 
ion immunoassay based on antibodies induced by CMPA. 
In our lab, we have successfully synthesized two types of 
metal ion hapten: CMPA for copper ions and a mercuric 
mercaptide of penicillenic acid (MMPA) for mercury ions 
[31]. However, the synthesis system used for mercury and 
copper ion haptens is not suitable for other metal ions, e.g., 
Pb(II), Cr(III), Co(II), Cr(III), Pb(III), Ni(II). Furthermore, 
with a simple pretreatment of sample to remove mercury 
ions, we could utilize the antibody recognition for copper 
ions with CMPA instead to determine the concentration of 
copper ions in environmental and food samples. This meth-
od may offer a novel strategy for the immunoassay of heavy 
metal ions in the future.  
3  Conclusion 
In this paper, based on prior advances [32,33,35,36], we 
successfully synthesized a novel copper ion hapten CMPA 
from a penicillin derivative. The final results indicate that (i) 
CMPA is stable both in vitro and in vivo and is safe for 
immunized animals, with no toxic phenomena found during 
immunizations; (ii) the novel synthesized antigen (CMPA- 
BSA) could stimulate the immune system to produce spe-
cific affinity with high titrations up to 150000; (iii) antibod-
ies in the antisera showed a higher affinity against coating 
antigen OVA-GSH-CuCl than that against OVA-GSH, in-
dicating the existence of the specific antibodies against 
copper ions in the antisera. In addition, we found that the 
coupling ratio of CMPA and BSA has a significant influ-
ence on the immune response of animals, in accordance 
with a previously determined principle, namely that a higher 
coupling ratio usually increases the strength and specificity 
of the immune response [30,37]. 
Our results show that the novel synthesized copper anti-
gen (CMPA-BSA) clearly has potential as an immunoassay 
for detecting copper ions in the environment and food sam-
ples. Meanwhile, this novel method for synthesis of a hap-
ten for copper ions opens up a new way forward for the de-
sign of haptens for heavy metal ion detection by immuno-
assay.  
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